Gemphire Therapeutics Inc. Business Finance Contracts & Agreements
48 Contracts & Agreements
- Investor Rights Agreements (2 contracts)
- Loan Agreements (2)
- Note Agreements (2)
- Purchase Agreements (7)
- Registration Rights Agreements (4)
- Release Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (5)
- Warrant Agreements (20)
- Form of Registration Rights Agreement, dated as of June 23, 2024, by and among the Company and the Purchasers identified on the signature pages thereto (Filed With SEC on June 25, 2024)
- Form of Securities Purchase Agreement, dated as of June 23, 2024, by and among the Company and the Purchasers identified on the signature pages thereto (Filed With SEC on June 25, 2024)
- Form of Securities Purchase Agreement, dated as of June 23, 2024, by and among the Company and the Purchaser identified on the signature page thereto (Filed With SEC on June 25, 2024)
- Form of Placement Agent Warrant (Filed With SEC on June 25, 2024)
- Form of Series B Warrant (Filed With SEC on June 25, 2024)
- Form of Series A Warrant (Filed With SEC on June 25, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on June 25, 2024)
- Amendment to Dong-A Series B Warrant (Filed With SEC on April 14, 2023)
- Amendment to Dong-A Series A Warrant (Filed With SEC on April 14, 2023)
- Form of Dong-A Series B Warrant to purchase shares of common stock (Filed With SEC on November 8, 2022)
- Form of Dong-A Series A Warrant to purchase shares of common stock (Filed With SEC on November 8, 2022)
- Warrant Agency Agreement (Filed With SEC on November 8, 2022)
- Form of Series B Warrant to purchase shares of common stock (Filed With SEC on November 8, 2022)
- Form of Series A Warrant to purchase shares of common stock (Filed With SEC on November 8, 2022)
- Underwriting Agreement dated as of November 4, 2022, by and between NeuroBo Pharmaceuticals, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on November 8, 2022)
- Form of Series B Warrant offered hereby (Filed With SEC on November 3, 2022)
- Form of Series A Warrant offered hereby (Filed With SEC on November 3, 2022)
- Form of Underwriting Agreement between the Registrant and Ladenburg Thalmann & Co. Inc (Filed With SEC on November 3, 2022)
- Form of Warrant offered hereby (Filed With SEC on October 24, 2022)
- Form of Warrant Agency Agreement between the Registrant and American Stock Transfer & Trust Company (Filed With SEC on October 24, 2022)
- Form of Underwriting Agreement between the Registrant and Ladenburg Thalmann & Co. Inc (Filed With SEC on October 24, 2022)
- Investor Rights Agreement, by and between Dong-A ST Co. Ltd. and the Company, dated September 14, 2022 (Filed With SEC on September 14, 2022)
- Registration Rights Agreement, by and among Dong-A ST Co., Ltd., The E&Healthcare Investment Fund II, The E&Healthcare Investment Fund No. 6, The E&Healthcare Investment Fund No.... (Filed With SEC on September 14, 2022)
- Securities Purchase Agreement, by and between Dong-A ST Co., Ltd. and the Company, dated September 14, 2022 (Filed With SEC on September 14, 2022)
- Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the NeuroBo Pharmaceuticals, Inc. 2021 Inducement Plan (Filed With SEC on November 4, 2021)
- Form of Securities Purchase Agreement, dated as of October 1, 2021, by and among NeuroBo Pharmaceuticals, Inc. and the purchasers identified on the signature pagers thereto (Filed With SEC on October 4, 2021)
- Form of Warrant to purchase shares of common stock (Filed With SEC on October 4, 2021)
- RELEASE AGREEMENT (Filed With SEC on August 16, 2021)
- Form of Registration Rights Agreement (Filed With SEC on January 21, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on January 21, 2021)
- Form of Warrant (Filed With SEC on January 21, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on April 15, 2020)
- Form of Placement Agents Warrant (Filed With SEC on April 15, 2020)
- Form of Notice of Grant of Stock Option for NeuroBo Pharmaceuticals, Inc. to the 2018 Stock Plan (Filed With SEC on September 3, 2019)
- Form of Notice of Grant of Restricted Stock Purchase Right for NeuroBo Pharmaceuticals, Inc. to the 2018 Stock Plan (Filed With SEC on September 3, 2019)
- Form of Stock Option Agreement for NeuroBo Pharmaceuticals, Inc. to the 2018 Stock Plan (Filed With SEC on September 3, 2019)
- 2018 Stock Plan for NeuroBo Pharmaceuticals, Inc (Filed With SEC on September 3, 2019)
- First Amendment to Loan and Security Agreement, dated as of July 31, 2018, by and between Gemphire Therapeutics Inc. and Silicon Valley Bank (Filed With SEC on August 6, 2018)
- Warrant to Purchase Stock, dated July 31, 2018, by and between Gemphire Therapeutics Inc. and Silicon Valley Bank (Filed With SEC on August 6, 2018)
- 3,142,858 Shares Gemphire Therapeutics Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 12, 2018)
